Cresco Labs Inc.
CL
CNSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -10.54M | -54.33M | -5.19M | 2.64M | -115.57M |
| Total Depreciation and Amortization | 16.62M | 16.44M | 17.30M | 21.96M | 17.01M |
| Total Amortization of Deferred Charges | 1.26M | 1.21M | 1.18M | 1.16M | 1.13M |
| Total Other Non-Cash Items | 8.04M | 68.45M | 12.59M | -1.02M | 116.63M |
| Change in Net Operating Assets | 33.98M | -14.61M | 10.60M | -28.03M | 21.43M |
| Cash from Operations | 49.36M | 17.16M | 36.47M | -3.30M | 40.62M |
| Capital Expenditure | -6.07M | -6.43M | -3.78M | -4.82M | -12.45M |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 397.00K | 6.64M | 157.00K |
| Cash Acquisitions | 0.00 | -3.23M | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -197.00K | -606.00K | -2.29M | 783.00K | -181.00K |
| Cash from Investing | -6.27M | -10.27M | -5.68M | 2.61M | -12.48M |
| Total Debt Issued | -- | -- | -- | 0.00 | 20.18M |
| Total Debt Repaid | -1.26M | -1.07M | -1.10M | -1.01M | -1.39M |
| Issuance of Common Stock | 0.00 | 7.00K | 2.00K | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -200.00K | -- | -- | -- | -- |
| Other Financing Activities | -1.00M | -14.76M | -10.05M | -2.77M | -8.73M |
| Cash from Financing | -2.46M | -15.83M | -11.15M | -3.78M | 10.05M |
| Foreign Exchange rate Adjustments | -25.00K | -10.00K | -13.00K | -21.00K | 7.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 40.61M | -8.95M | 19.63M | -4.50M | 38.21M |
